Featured 13F manager
DME Capital Management David Einhorn
David Einhorn New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 Positions
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN 3.1%
- PCG 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Latest book
| GRBK - Green Brick Partners | 19.39% | Hold | 9,467,383 | $80.04 | $758M | — | — |
| FLR - Fluor | 6.24% | Reduce −1.9% | 4,658,750 | $52.39 | $244M | −88,600 | +$23M |
| CNR - Core Natural Resources | 4.67% | Add +22.9% | 2,283,200 | $80.02 | $183M | +425,060 | −$12M |
| BHF - Brighthouse Finl | 4.60% | Hold | 2,842,100 | $63.30 | $180M | — | — |
| ACHC | 3.32% | Reduce −2.6% | 4,400,641 | $29.53 | $130M | −117,740 | +$24M |
| PENN - Penn Entertainment | 3.20% | Reduce −3.0% | 5,860,270 | $21.36 | $125M | −184,170 | +$34M |
| FBIN | 3.15% | New | 2,241,875 | $54.90 | $123M | +2,241,875 | +$123M |
| PCG | 2.85% | Hold | 6,632,852 | $16.82 | $112M | — | — |
| CNC - Centene Del | 2.71% | Reduce −39.6% | 1,651,150 | $64.19 | $106M | −1,080,660 | +$17M |
| PKG - Graphic Packaging | 2.69% | Add +9.4% | 9,953,430 | $10.57 | $105M | +853,450 | +$15M |
| SNX - Td Synnex | 2.61% | Reduce −20.5% | 381,042 | $267.34 | $102M | −98,488 | +$21M |
| TEVA - Teva Pharmaceutical Inds | 2.50% | Reduce −0.8% | 2,886,059 | $33.88 | $98M | −24,670 | +$10M |
| VGNT - Versigent | 2.45% | New | 2,277,640 | $42.01 | $96M | +2,277,640 | +$96M |
| Capri | 2.29% | Reduce −2.2% | 4,820,118 | $18.57 | $90M | −110,200 | +$3M |
| BKV | 2.17% | Add +14.8% | 3,095,173 | $27.36 | $85M | +399,630 | +$8M |
| DHT | 2.13% | Reduce −4.5% | 5,034,320 | $16.53 | $83M | −238,450 | −$13M |
| CROX - Crocs | 2.07% | Hold | 669,140 | $120.64 | $81M | — | — |
| ROIV - Roivant Sciences | 1.95% | Hold | 2,152,669 | $35.39 | $76M | — | — |
| SHC - Sotera Health | 1.88% | Add +100.2% | 4,135,515 | $17.75 | $73M | +2,069,835 | +$44M |
| VSNT - Versant Media Group · CL A | 1.77% | Reduce −36.5% | 1,922,172 | $36.01 | $69M | −1,106,443 | −$43M |
| PRMB - Primo Brands · CLASS A | 1.77% | New | 2,823,660 | $24.44 | $69M | +2,823,660 | +$69M |
| DCH - Dauch | 1.72% | Add +96.4% | 12,395,104 | $5.42 | $67M | +6,083,754 | +$30M |
| PYPL - Paypal | 1.57% | New | 1,424,320 | $43.18 | $62M | +1,424,320 | +$62M |
| HSIC - Schein Henry | 1.54% | Add +19.9% | 718,550 | $83.52 | $60M | +119,250 | +$16M |
| WBD - Warner Bros Discovery | 1.53% | New | 2,246,180 | $26.66 | $60M | +2,246,180 | +$60M |
| LBTYA - Liberty Global · CL A | 1.44% | Hold | 4,963,322 | $11.37 | $56M | — | — |
| AR - Antero Resources | 1.42% | Add +94.7% | 1,574,140 | $35.14 | $55M | +765,620 | +$21M |
| STUB - Stubhub · CL A | 1.39% | Hold | 4,233,200 | $12.87 | $54M | — | — |
| REZI - Resideo Technologies | 1.35% | Add +7.9% | 1,699,590 | $31.10 | $53M | +124,640 | −$234K |
| DECK - Deckers Outdoor | 1.29% | Add +5.2% | 506,398 | $99.29 | $50M | +25,000 | +$2M |
| SPB - Spectrum Brands | 1.23% | Reduce −13.7% | 561,438 | $85.75 | $48M | −88,921 | +$212K |
| Cnh Indl N V | 1.20% | Hold | 4,188,940 | $11.23 | $47M | — | — |
| VTRS - Viatris | 1.13% | Add +52.6% | 2,773,470 | $15.88 | $44M | +955,900 | +$19M |
| PARA - Paramount Skydance · CL B | 0.99% | Hold | 3,926,080 | $9.86 | $39M | — | — |
| PVH | 0.99% | New | 520,800 | $74.26 | $39M | +520,800 | +$39M |
| CMCSA - Comcast · CL A | 0.85% | New | 1,345,780 | $24.55 | $33M | +1,345,780 | +$33M |
| Slide Ins | 0.84% | Hold | 1,686,630 | $19.37 | $33M | — | — |
| TCOM - Tripadvisor | 0.83% | Add +51.0% | 2,361,973 | $13.71 | $32M | +797,277 | +$16M |
| GLD - Spdr Gold Tr | 0.79% | Reduce −16.3% | 83,421 | $368.38 | $31M | −16,190 | −$12M |
| CI - The Cigna Group | 0.62% | Hold | 88,400 | $275.68 | $24M | — | — |
| LKFT | 0.37% | Hold | 482,746 | $29.98 | $14M | — | — |
| COYA - Coya Therapeutics | 0.35% | Hold | 2,335,540 | $5.85 | $14M | — | — |
| IMVT - Immunovant | 0.09% | Hold | 93,520 | $38.53 | $4M | — | — |
| GPRO - Gopro · CL A | 0.03% | Hold | 1,693,860 | $0.7780 | $1M | — | — |
| GANX - Gain Therapeutics | 0.03% | Hold | 566,130 | $2.03 | $1M | — | — |
| NUVB - Nuvation Bio · CL A | 0.01% | Hold | 34,995 | $5.68 | $199K | — | — |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2026 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Victorias Secret And | 3.28% | Exit | 0 | $46.36 | $105M | −2,256,889 | −$105M |
| SLM | 1.41% | Exit | 0 | $21.41 | $45M | −2,101,840 | −$45M |
| PTON - Peloton Interactive · CL A | 1.36% | Exit | 0 | $4.29 | $43M | −10,113,940 | −$43M |
| WFRD - Weatherford Intl | 0.43% | Exit | 0 | $94.58 | $14M | −145,721 | −$14M |
| Holding | 0.29% | Exit | 0 | $26.35 | $9M | −354,526 | −$9M |
| Katapult | — | Exit | 0 | $0.0038 | $1K | −262,227 | −$1K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | entity change | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
SEC: DME Capital Management, LP
20 processed 13Fs on this site · 2021 Q3–2026 Q2